Pharmaceutical composition
    3.
    发明公开
    Pharmaceutical composition 有权
    Pharmazeutische Zusammensetzung

    公开(公告)号:EP1269860A1

    公开(公告)日:2003-01-02

    申请号:EP02078716.4

    申请日:1999-06-04

    IPC分类号: A23L1/308 A61K45/06 A61K38/54

    摘要: Pharmaceutical composition comprising:

    an hypocholesterolemic agent, said hypocholesterolemic agent being preferably selected from the group consisting of benfluorex and ursodesoxycolic acid;
    an hypotriglyceride agent, said hypotriglyceride agent being preferably benfluorex;
    a lipasic and proteasic agent, said lipasic and proteasic agent being preferably pancreatine IX F.U.;
    an hypoglycemic agent, said hypoglycemic agent being preferably metformine and
    an hydrocoleretic agent, said hydrocoleretic agent being preferably selected from the group consisting of Na dehydrocloate and ursodesoxycolic acid.

    Said pharmaceutical composition can be used in preventing or treating the side-effects caused by ketogenic diets.

    摘要翻译: 药物组合物,其包含:低胆固醇血症药,所述降胆固醇剂优选选自苯芴和尿酸氧基酸; 甘油三酯试剂,所述甘油三酯试剂优选为本芴; 所述脂肪酸和蛋白酶优选为胰腺IX F.U。 降血糖剂,​​所述降血糖剂优选为二甲双胍和加氢共沉淀剂,所述加氢脱色剂优选选自脱氢脱水山梨酸钠和尿烷氧基聚乙酸钠。 所述药物组合物可用于预防或治疗由致生物饮食引起的副作用。